Health Condition 1: I249- Acute ischemic heart disease, unspecified
Conditions
Interventions
None listed
Sponsors
Cardiovascular Research Society Kerala
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age more than 18 years 2. Any bifurcation coronary stenosis undergoing bifurcation coronary stenting. 3. Two or bifurcations in same patients are eligible, as long as only one bifurcation per vessel. 4. Patients with another single lesion in different vessels could be treated as indicated
Exclusion criteria
Exclusion criteria: 1. Patients with expected survival less than one year 2. Recent CVA 3. Allergic to aspirin, clopidogrel, ticagrelor are excluded 4. Active cancer 5. Inability to provide consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composite end point of major adverse cardiac events (MACE) includes cardiac death, target lesion myocardial infarction (MI), and ischemia-driven target lesion revascularisation (TLR)Timepoint: 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Cardiac death, All-cause mortality, Any Myocardial Infarction (MI), Target lesion myocardial infarction, Target lesion revascularisation (TLR), Stent thrombosis, Target vessel revascularisation, Any Revascularisation and Angina. Number of stents implanted in BCI, Total stent length in BCI, Drug eluting balloon(DEB), Bifurcation strategy, side branch rewiring (SBR) rewiring, Final Kissing Balloon (FKB), Proximal optimisation-side branch-proximal optimisation(PSP) and Imaging.Timepoint: at In-hospital, 1, 12, 24 and 36 months | — |
Countries
India
Contacts
Public ContactDr Rony Mathew
Lisie Hospital
Outcome results
None listed